Nano Dimension Ltd - ADR vs Roivant Sciences Ltd. Common Shares — how do they compare? Nano Dimension Ltd - ADR trades at $1.55 (market cap $328.52M), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 75.2× Nano Dimension Ltd - ADR's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nano Dimension Ltd - ADR for 43 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| NNDM | ROIV | |
|---|---|---|
Market Cap | $328.52M | $24.72B |
Volume | 1,160,945 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $2.14 | $41.81 |
52-Week Low | $1.21 | $16.04 |
Typical Hold Time | 43 Days | 1 Days |
Enterprise Value | -$76.33M | $20.99B |
Signals from Pluang's Aura AI — not financial advice
Nano Dimension (NNDM) trades at $1.56, up 0.65% with a bearish technical signal. The company shows revenue growth from $102M in 2025 to $121M in 2026 but remains unprofitable with a -135% net margin. Recent strategic actions include cost-cutting initiatives and board changes, with cash reserves of $758M providing operational runway despite negative cash flows.
The outlook remains challenging with persistent losses and negative cash flow, though valuation ratios appear attractive with P/S of 2.73 and P/B of 0.68. Key risks include execution of turnaround strategy and competitive pressures in the industrial 3D printing sector. Analyst sentiment is cautious given the company's ongoing restructuring efforts.
No Aura AI signal available yet.
Trailing returns across standard periods
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →